Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Josh Gad, weight loss
Josh Gad Reveals Weight Loss From GLP-1 Medication, Changing Relationship With Food
GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many celebrities have joined the ranks of those who swear by the medication, including Josh Gad, who opened up about his experience for the first time this week.
Josh Gad reveals he had to stop taking weight-loss drug due to side effects: ‘Really bummed out’
The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different drug.
Josh Gad opens up for 1st time about taking weight loss drug: 'It is life-changing'
During his appearance on the " Armchair Expert " podcast on Monday, the "Frozen" actor opened up about taking weight loss medication. "I’m on a GLP-1," Gad revealed during the conversation with Dax Shepard and Monica Padma, noting that this is his first time speaking out publicly about the topic.
Josh Gad Reveals 'Life-Changing' 40-Lb. Weight Loss
Despite his success, Gad admitted that finding the right approach wasn't easy. After losing the initial weight, he faced an unexpected setback when the first medication he tried c
Josh Gad Reveals He’s Lost 40-Lbs. After Taking Weight Loss Medication
Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.
Josh Gad Makes Bold Declaration About Weight Loss Drugs After Losing 40 Pounds
Josh Gad is the latest celebrity to talk about using a weight loss medication—and while his experience has been positive, he does have some doubts about his transformation. “I’m on a GLP-1...this is the first time I’ve opened up about this,
23h
An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
9d
on MSN
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
KIVI-TV
39m
Maintaining weight loss: Tips for staying healthy after GLP-1 medication
Dr. Daniel Meltzer, a weight loss expert, suggests that it's possible to maintain weight loss after using GLP-1 medications by creating proper habits, including exercise and eating well. He emphasizes ...
8d
on MSN
GLP-1 weight loss drugs linked to a wide range of health benefits and risks: study
A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, ...
1d
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
IFLScience
9d
Not Just For Weight Loss: GLP-1 Drugs May Affect Addiction And Dementia Risk
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
8d
on MSN
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
1d
on MSN
Hollywood star feels he’s ‘cheating’ after losing 40 pounds with weight loss drug
Hollywood actor Josh Gad feared his identity would shift after he lost 40 pounds being on a "miracle" weight loss drug.
KIVI-TV
18h
Wellness Wednesday: Healthy habits key to maintaining weight loss after GLP-1 treatment
Maintaining weight loss after GLP-1 treatment is challenging — get expert tips on how to keep those pounds off for good.
1d
on MSN
Are Weight-Loss Drugs Like Gym Memberships? The Answer Is Worth Billions
An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback